Bell Media unveiled its 2025/26 lineup of English and French-language original content today, featuring a total of 116 titles of premium original content and documentaries. The exciting slate ...

Mediar Therapeutics, Inc., a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced the first patient has been dosed in its Phase 2 WISPer ...

How do you conserve 80-year-old murals that have accumulated decades' worth of soot, salt and other deterioration?

Now, let's return to our question: Should you invest $1,000 in Lilly right now? The shares are trading for 34 times forward ...

In May 2025, Eli Lilly and Company conducted a study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better. The study will ...

This was the stock's fifth consecutive day of gains.

Lilly's SVP of Talent said diverse backgrounds, skills and perspectives "fuel" innovation and "strengthen the understanding ...

As Merck & Co., Bristol Myers Squibb and Pfizer have hopped on the PD-(L)1xVEGF bispecific bandwagon, the question becomes ...

Eli Lilly (NYSE: LLY) has been one of the top-performing healthcare megacap stocks of the past decade. Eli Lilly is ...

Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...

Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...

In recent episodes of the daytime soap opera The Young and the Restless, everyone in Genoa City seems to be talking about a mysterious billionaire, Aristotle Dumas, whose identity remains unknown.